Proposed Special Review Decision PSRD2020-04, Special Reviews of Pymetrozine and Its Associated End-use Products
Before making a special review decision on pymetrozine, Health Canada will consider all comments received from the public in response to PSRD2020-04. A science-based approach will be applied in making a final decision on pymetrozine. Health Canada will then publish a special review decision...
Organization:
Health Canada
Resource Formats:
- HTML